Notice Type
Departmental
Notice Title

Notice of Reassessment of Registered Trade Name Products (Notice No. MPI 1010)

I, Maree Zinzley, Manager Approvals Operations, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, give notice, under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), that a decision has been made to reassess the following trade name products under section 29 of the Act.

Purpose of Reassessment

The reassessment of the trade name products listed below are to establish whether a condition should be imposed on the registration of each of the trade name products listed below. Those trade name products are all antibiotics. The proposed condition would prohibit the advertising of the trade name product, being an antibiotic, to the end-users.

The Trade Name Products to be Reassessed are:

Reference

Trade Name

Active ingredients and concentrations

A000829

MASTALONE

Neomycin Sulphate, Oleandomycin, Oxytetracycline Hydrochloride, Prednisolone,

A000888

ORBENIN DRY COW

Cloxacillin Benzathine,

A001350

NEOMIX CONCENTRATE

Neomycin Sulphate,

A001862

TERRAMYCIN PINKEYE POWDER

Oxytetracycline Hydrochloride,

A002098

LINCO-SPECTIN SOLUBLE POWDER

Lincomycin Hydrochloride, Spectinomycin Sulphate,

A003664

ORBENIN LA

Cloxacillin Sodium (Anhydrous),

A004751

ORBENIN EYE OINTMENT

Cloxacillin Benzathine,

A004925

CLAVULOX Palatable Drops

Amoxycillin Trihydrate, Potassium Clavulanate,

A005722

CLAVULOX READY TO USE INJECTION

Amoxycillin Trihydrate, Potassium Clavulanate,

A005945

CLAVULOX LC

Amoxicillin, Clavulanic Acid, Prednisolone,

A006036

ORBENIN ENDURO

Cloxacillin Benzathine,

A006077

VIBRAVET 100 PASTE FOR CATS & DOGS

Doxycycline,

A006078

VIBRAVET 50 TABLETS FOR CATS & DOGS

Doxycycline,

A006812

EXCENEL

Ceftiofur,

A006893

ANTIROBE AQUADROPS

Clindamycin Hydrochloride,

A006894

Antirobe Antibiotic Capsules 75mg

Clindamycin Hydrochloride,

A006895

Antirobe Antibiotic Capsules 25mg

Clindamycin Hydrochloride,

A006928

VIBRAVET 100 TABLETS FOR LARGE DOGS

Doxycycline,

A007933

Aurofac 200G

Chlortetracycline,

A008139

Clavulox Palatable Tablets Broad Spectrum Antibiotic 50mg

Amoxycillin Trihydrate, Potassium Clavulanate,

A008140

Clavulox Palatable Tablets Broad Spectrum Antibiotic 250mg

Amoxycillin Trihydrate, Potassium Clavulanate,

A008141

Clavulox Palatable Tablets Broad Spectrum Antibiotic 500mg

Amoxycillin Trihydrate, Potassium Clavulanate,

A008150

Antirobe Antibiotic Capsules 150mg

Clindamycin Hydrochloride,

A010032

Convenia

Cefovecin Present As Cefovecin Sodium,

A010150

Excede LA Sterile Suspension.

Ceftiofur,

A010299

Simplicef

Cefpodoxime Proxetil,

A010814

Draxxin Injectable Antibiotic Solution

Tulathromycin,

A011175

Cefaclear

Cephalonium,

A011314

Excenel® Flow

Ceftiofur Present As Ceftiofur Hydrochloride,

Further information about each of the trade name products listed above, including its intended use, can be found on the ACVM Register that is available on MPI’s website: https://eatsafe.nzfsa.govt.nz/web/public/acvm-register.

Any person may make a written submission to the director-general concerning this reassessment.

Each submission must state the trade name product(s) the submission pertains to.

Under sections 16 and 17 of the Act, a written submission:

  1. must state in full the reasons for making the submission; and
  2. may state any decision sought on that application; and
  3. must be received by the director-general no later than 30 working days after the date of notification in the New Zealand Gazette.

Under section 18 of the Act, a copy of every submission will be forwarded to the registrant for the registrant’s information.

The following address is:

  1. where submissions on this application are to be sent; and
  2. where requests for copies of the public information relating to the application can be sent; and
  3. where public information relating to the application can be viewed; and
  4. the director-general’s address for service:

ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.

The registrant’s address for service is:

Zoetis New Zealand Limited, PO Box 2094, Shortland Street, Auckland 1140.

Dated at Wellington this 10th day of April 2019.

MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).